Storage and manufacturing expenses include outdated storage and storage costs for certain product lines we want to implement, as well as other storage and manufacturing costs. During the nine-month period ended September 30, 2019, storage and manufacturing costs also included a US$20.8 million charge for the termination of a raw material supply agreement. Warsaw`s urban group, rivals IN Zimmer Holdings Inc. and Biomet completed their merger on Thursday, after the Federal Trade Commission provisionally approved plans for companies to divest products that the FTC said would limit trade. The company will hold its investor conference in the third quarter of 2020 today, November 6, 2020, at 8:30 .m a.m. ET. The audio webcast is available at investor.zimmerbiomet.com via Zimmer Biomet`s Investor Relations website. It will be archived after the conference call for reading. Here is an example of the company`s major mergers, acquisitions and historical predecessors: companies have 10 days to meet the proposed comparison after the merger is completed, the agency said. They plan to finalize the divestitures within a week, according to Monica Kendrick, the company`s representative.
The agreement will be commented on publicly for 30 days, from today until 24 July 2015, after which the Commission will decide to make the proposed approval opinion final. In the years following Zimmer`s $14-billion merger with Biomet, the company faced delivery and other problems, which gave CEO Hanson some turnaround work when he took over as leader at the end of 2017. One of the priorities was to increase the growth rate of the company. After looking at Zimmer Biomet`s balance sheet, Needham analysts believe the company is able to meet with companies to meet its growth targets. The Company still expects the transaction to close in the first quarter of 2015. Under the merger agreement announced on April 24, Zimmer will acquire Biomet in a cash and equity transaction worth approximately $13.35 billion, including the acquisition of net debt. We regularly publish important investor information on our website, www.zimmerbiomet.com, in the area of investor relations. We use this site as a means of disclosing essential and non-public information and fulfilling our advertising obligations under FD Regulation.
As a result, investors should monitor the Investor Relations section on our website, in addition to our press releases, SEC submissions, public conference calls, presentations and webcasts. Information contained or accessible on our website that can be accessed through our website is not included in this document by reference and is not part of this document. Zimmer Biomet estimates that the steady growth in non-biomet currency revenue in the second quarter of 2015 is in the range of 1.0% to 1.5% and 1.5% to 2.0% in constant currency account. For the whole of 2015, sales are expected to be stable compared to pro forma 2014 and sales are now expected to increase between 1.5% and 2.0%. Previously, the company had estimated that sales in constant currency for the full year would increase from 1.5% to 2.5% compared to pro forma sales in 2014.